6 results
management diagnosis algorithm cancer malignancy vte afib atrial cardiomyopathy essential et fibrillation leukemia peripartum thrombocythemia treatment
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis. Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... anticoagulants (DOACs ... Cancer #Algorithm #Anticoagulation ... #Management #Hematology ... #Oncology
►
 Treatment algorithm for VTE in Malignancy (A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
VTE and bleeding complications ... DOAC, direct oral ... Cancer #Algorithm #Anticoagulation ... #Management #Hematology ... #Oncology
Peripartum Cardiomyopathy - Summary 1. Definition • Towards the end of pregnancy to 5 months postpartum
exclude other causes ... Avoid Warfarin and DOAC ... Thromboembolic complications ... suggest prophylactic anticoagulation ... diagnosis #management #cardiology
Atrial Fibrillation (A-Fib) Summary Symptoms: • Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope. Why? Cardiac: • Valvular heart
early Afib and pts ... cardiovascular risk ... TSH level (< 5% pts ... typically needed • DOACs ... diagnosis #management #cardiology
Leukemias Overview: ALL, CML, AML, APML, CLL Acute leukemias > 20% blasts in the peripheral blood smear
-> AML: Blast crises ... count ↑ PLT • ↑ PBS ... Transformation: • Complication ... #Leukemia #Hematology ... #Oncology #Diagnosis
Essential Thrombocythemia (ET) ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
Most cases are related ... , symptoms and complications ... appropriate only for low risk ... patients with no CV risk ... Hydroxyurea + anticoagulation
No results found for "PNS hematology causes risk cardiology complications oncology anticoagulation doac"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #PNS #hematology #causes #risk #cardiology #complications #oncology #anticoagulation #doac